ID   ALS-iPS2
AC   CVCL_L642
DR   SKIP; SKIP005480
DR   Wikidata; Q54749303
RX   PubMed=22673189;
CC   From: Guangzhou Medical University; Guangzhou; China.
CC   HLA typing: A*02,31; B*75,48 (PubMed=22673189).
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=22673189
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18
ST   D13S317: 8,9
ST   D16S539: 9,10
ST   D18S51: 12,13
ST   D19S433: 14.2,15
ST   D21S11: 29,32.2
ST   D2S1338: 19,25
ST   D3S1358: 17
ST   D5S818: 10,11
ST   D6S1043: 13,14
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 19,22
ST   Penta D: 9,12
ST   Penta E: 10,14
ST   TH01: 6,9
ST   TPOX: 8,11
ST   vWA: 14,17
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_L641 ! ALS-iPS1
SX   Male
AG   54Y
CA   Induced pluripotent stem cell
DT   Created: 06-05-13; Last updated: 10-09-24; Version: 14
//
RX   PubMed=22673189; DOI=10.1262/jrd.2012-059;
RA   Luo, Yu-Mei
RA   Fan, Yong
RA   Chen, Xin-Jie
RA   Yu, Bo-Lan
RA   Yue, Lei
RA   Wang, Ding
RA   Li, Qing
RA   Chen, Yao-Yong
RA   Sun, Xiao-Fang
RT   "Generation of induced pluripotent stem cells from Asian patients with
RT   chronic neurodegenerative diseases.";
RL   J. Reprod. Dev. 58:515-521(2012).
//